Physician profile
Eric Chen
NPI 1578521779
$3,257.36
in general payments reported to CMS, 2019-2025
12 companies · $949 in 2025
The $949 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.70 · 2020: $92.52 · 2021: $182 · 2022: $403 · 2023: $585 · 2024: $981 · 2025: $949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,515.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,502.13 | 2020-2025 | Eylea Hd, Eylea |
| Astellas Pharma US INC | $451.44 | 2023-2025 | Izervay |
| Apellis Pharmaceuticals, INC. | $377.87 | 2023-2025 | Syfovre |
| Genentech USA, INC. | $201.95 | 2019-2025 | Vabysmo |
| Abbvie INC. | $189.41 | 2023-2025 | Ozurdex |
| Janssen Pharmaceuticals, INC | $160.75 | 2024 | Spravato, Invega Sustenna |
| Alimera Sciences, INC. | $141.64 | 2022-2024 | Iluvien, Yutiq |
| Biogen, INC. | $95.31 | 2022-2024 | Byooviz |
| Alcon Vision LLC | $54.58 | 2020-2025 | Clareon |
| Allergan, INC. | $36.32 | 2019 | |
| Servier Pharmaceuticals LLC | $24.95 | 2021 | |
| Rayner Intraocular Lenses Limited | $21.01 | 2025 | Rayone Spheric, Rayone Emv, Rayner Cataract Set 1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.